Meropenem/Vaborbactam: β-Lactam/β-Lactamase Inhibitor Combination, the Future in Eradicating Multidrug Resistance

被引：15

作者：

Duda-Madej, Anna ^{[1
]}

Viscardi, Szymon ^{[2
]}

Topola, Ewa ^{[2
]}

机构：

[1] Wroclaw Med Univ, Fac Med, Dept Microbiol, Chalubinskiego 4, PL-50368 Wroclaw, Poland

[2] Wroclaw Med Univ, Fac Med, Ludw Pasteura 1, PL-50367 Wroclaw, Poland

来源：

ANTIBIOTICS-BASEL | 2023年 / 12卷 / 11期

关键词：

beta-lactam/beta-lactamase inhibitor; carbapenem-resistant Enterobacterales (CRE); Klebsiella pneumoniae carbapenemase (KPC); meropenem; multidrug resistance; vaborbactam; URINARY-TRACT-INFECTION; MEROPENEM-VABORBACTAM; ENTEROBACTERIACEAE; RPX7009; PREVENTION; PNEUMONIA; STABILITY;

D O I：

10.3390/antibiotics12111612

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Due to the fact that there is a steadily increasing trend in the area of antimicrobial resistance in microorganisms, there is a need to look for new treatment alternatives. One of them is the search for new beta-lactamase inhibitors and combining them with beta-lactam antibiotics, with the aim of increasing the low-dose efficacy, as well as lowering the resistance potential of bacterial strains. This review presents the positive effect of meropenem in combination with a vaborbactam (MER-VAB). This latest antibiotic-inhibitor combination has found particular use in the treatment of infections with the etiology of carbapenem-resistant Enterobacterales (CRE), Gram-negative bacteria, with a high degree of resistance to available antimicrobial drugs.

引用

页数：17

共 74 条

[41] The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace [J].

Logan, Latania K. ;

Weinstein, Robert A. .

JOURNAL OF INFECTIOUS DISEASES, 2017, 215 :S28-S36

[42]

Lomovskaya O, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01443-17, 10.1128/aac.01443-17]

[43] Thermal and alkaline stability of meropenem: Degradation products and cytotoxicity [J].

Mendez, Andreas ;

Chagastelles, Pedro ;

Palma, Eduardo ;

Nardi, Nance ;

Schapoval, Elfrides .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 350 (1-2) :95-102

[44] Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections [J].

Morrill, Haley J. ;

Pogue, Jason M. ;

Kaye, Keith S. ;

LaPlante, Kerry L. .

OPEN FORUM INFECTIOUS DISEASES, 2015, 2 (02)

[45] Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis [J].

Murray, Christopher J. L. ;

Ikuta, Kevin Shunji ;

Sharara, Fablina ;

Swetschinski, Lucien ;

Aguilar, Gisela Robles ;

Gray, Authia ;

Han, Chieh ;

Bisignano, Catherine ;

Rao, Puja ;

Wool, Eve ;

Johnson, Sarah C. ;

Browne, Annie J. ;

Chipeta, Michael Give ;

Fell, Frederick ;

Hackett, Sean ;

Haines-Woodhouse, Georgina ;

Hamadani, Bahar H. Kashef ;

Kumaran, Emmanuelle A. P. ;

McManigal, Barney ;

Agarwal, Ramesh ;

Akech, Samuel ;

Albertson, Samuel ;

Amuasi, John ;

Andrews, Jason ;

Aravkin, Aleskandr ;

Ashley, Elizabeth ;

Bailey, Freddie ;

Baker, Stephen ;

Basnyat, Buddha ;

Bekker, Adrie ;

Bender, Rose ;

Bethou, Adhisivam ;

Bielicki, Julia ;

Boonkasidecha, Suppawat ;

Bukosia, James ;

Carvalheiro, Cristina ;

Castaneda-Orjuela, Carlos ;

Chansamouth, Vilada ;

Chaurasia, Suman ;

Chiurchiu, Sara ;

Chowdhury, Fazle ;

Cook, Aislinn J. ;

Cooper, Ben ;

Cressey, Tim R. ;

Criollo-Mora, Elia ;

Cunningham, Matthew ;

Darboe, Saffiatou ;

Day, Nicholas P. J. ;

De Luca, Maia ;

Dokova, Klara .

LANCET, 2022, 399 (10325) :629-655

[46] Pharmacokinetic and pharmacodynamic properties of meropenem [J].

Nicolau, David P. .

CLINICAL INFECTIOUS DISEASES, 2008, 47 :S32-S40

[47] Carbapenemase-producing Enterobacteriaceae: Overview of a major public health challenge [J].

Nordmann, P. .

MEDECINE ET MALADIES INFECTIEUSES, 2014, 44 (02) :51-56

[48] Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination [J].

Novelli, Andrea ;

Del Giacomo, Paola ;

Rossolini, Gian Maria ;

Tumbarello, Mario .

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2020, 18 (07) :643-655

[49] Measuring the global response to antimicrobial resistance, 2020-21: a systematic governance analysis of 114 countries [J].

Patel, Jay ;

Harant, Anne ;

Fernandes, Genevie ;

Mwamelo, Ambele Judith ;

Hein, Wolfgang ;

Dekker, Denise ;

Sridhar, Devi .

LANCET INFECTIOUS DISEASES, 2023, 23 (06) :706-718

[50] CURRENT CONCEPTS Hospital-Acquired Infections Due to Gram-Negative Bacteria [J].

Peleg, Anton Y. ;

Hooper, David C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (19) :1804-1813

← 1 2 3 4 5 6 7 8 →